These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Circadian variations in myelosuppressive activity of interferon-alpha in mice: identification of an optimal treatment time associated with reduced myelosuppressive activity. Koren S; Fleischmann WR Exp Hematol; 1993 Apr; 21(4):552-9. PubMed ID: 8462664 [TBL] [Abstract][Full Text] [Related]
5. Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2. Koren S; Fleischmann WR J Interferon Res; 1994 Dec; 14(6):343-7. PubMed ID: 7897253 [TBL] [Abstract][Full Text] [Related]
6. Modulation of peripheral leukocyte counts in mice by oral administration of interferons. Fleischmann WR; Fields EE; Wang JL; Hughes TK; Stanton GJ Proc Soc Exp Biol Med; 1991 Sep; 197(4):424-30. PubMed ID: 1714606 [TBL] [Abstract][Full Text] [Related]
7. Treatment of mice with macrophage colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta, and gamma interferons. Koren S; Klimpel GR; Fleischmann WR J Biol Response Mod; 1986 Oct; 5(5):481-9. PubMed ID: 3095498 [TBL] [Abstract][Full Text] [Related]
8. Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N: magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). Klimpel GR; Fleischmann WR; Klimpel KD J Immunol; 1982 Jul; 129(1):76-80. PubMed ID: 6177763 [TBL] [Abstract][Full Text] [Related]
9. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells. Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor. Means RT; Krantz SB Exp Hematol; 1996 Feb; 24(2):204-8. PubMed ID: 8641342 [TBL] [Abstract][Full Text] [Related]
11. Orally administered IFN-alpha acts alone and in synergistic combination with intraperitoneally administered IFN-gamma to exert an antitumor effect against B16 melanoma in mice. Fleischmann WR; Masoor J; Wu TY; Fleischmann CM J Interferon Cytokine Res; 1998 Jan; 18(1):17-20. PubMed ID: 9475662 [TBL] [Abstract][Full Text] [Related]
12. Macrophage colony stimulating factor (CSF-1) blocks the myeloid suppressive but not the antiviral or antiproliferative activities of murine alpha, beta, and gamma interferons in vitro. Koren S; Klimpel GR; Fleischmann WR J Biol Response Mod; 1986 Dec; 5(6):571-80. PubMed ID: 2432191 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Sidky YA; Borden EC Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862 [TBL] [Abstract][Full Text] [Related]
14. Can 29kDa rhGM-CSF expressed by silkworm pupae bioreactor bring into effect as active cytokine through orally administration? Zhang Y; Chen J; Lv Z; Nie Z; Zhang X; Wu X Eur J Pharm Sci; 2006 Jun; 28(3):212-23. PubMed ID: 16616462 [TBL] [Abstract][Full Text] [Related]
16. Studies of interferon as a regulator of hematopoietic cell proliferation. Raefsky EL; Platanias LC; Zoumbos NC; Young NS J Immunol; 1985 Oct; 135(4):2507-12. PubMed ID: 2411798 [TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of human interferons on erythroid colony growth in disorders of erythropoiesis. Lutton JD; Levere RD J Lab Clin Med; 1980 Aug; 96(2):328-33. PubMed ID: 6156973 [TBL] [Abstract][Full Text] [Related]
18. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro. Broxmeyer HE; Cooper S; Rubin BY; Taylor MW J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752 [TBL] [Abstract][Full Text] [Related]
20. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. Brod SA; Khan M J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]